Puma biotechnology inc

Major-Pharmaceuticals

PBYI


10880 Wilshire Boulevard
Los Angeles , CA 90024

Executive/
Director

Price

  • Last Close
  • $ 3
    $ +0.09 3.09 %
    Dec 10, 2024
  • 52-Week High/Low
  • $7.4 - $2.23
  • YTD
  • -30.7%

  • Trading Volume
  • 14,500
  • Market Cap Full
  • $ 142.7M
  • Shares Outstanding
  • 47.6M
    Oct 30, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 24.8% -62.5% 21.2% -31.2% 90.6% -5% -2.9% -5.3% -27% 22.4%
Q2 -50.6% 1.4% 135% -8.2% -64.2% 4% -7.8% -1% 14.2% -
Q3 -35.5% 125.1% 37% -22.9% -12.6% 8% -23.6% -16.8% -25.5% -
Q4 4% -54.2% -17.5% -56% -25.4% 1.7% -56.6% 78.5% 69.1% -
J F M A M J J A S O N D
2024 8.6% 32.3% -14.8% -0.4% - - - - - - - -
2023 1.7% -10.2% -20% -13.3% 25% 5.4% 2.6% 0.3% -27.6% -6.5% 58.5% 11%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    83%-59%-61%222%-79%-59%23%-70%39%2%-31%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.66 2.19 1.97 -0.65 -0.26 -0.43 0.4 -0.08 0.03
Q2 2.01 2.05 2.10 -1.17 -0.97 0.08 -0.13 0.21 0.05
Q3 1.87 2.02 2.07 -0.37 -0.44 -0.79 -1.09 -0.01 0.12
Q4 1.90 2.04 1.71 -0.8 -0.28 -0.38 0.1 -0.12 -
A 7.4 8.3 7.9 -3 -2 -1.5 -0.7 1.3877787807814E-17 0.2

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 38.5 39.3 40.3 41.3 46.6
Jun 37.8 38.6 39.4 40.4 45 46.7
Sep 38 38.9 39.7 40.8 45.6 47.5
Dec 38.1 39 39.8 40.9 45.6 47.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 11 9.1 13 12.3 11.7
Fixed Asset Turnover 38 36.1 32.1 30.2 20.9
Total Asset Turnover 1 1.1 0.9 1.2 1
Leverage
Debt Ratio 0.7 0.7 0.6 0.6 0.8
Debt – Equity Ratio 4.5 -48.5 -14 5.6 4.5
Interest Coverage 1 - -1 -1.1 -5
Equity multiplier 0.3 -3.5 -1.2 0.5 0.4